about
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathwa...
Read More
6.37
0.17
(2.74%)
1.2M
XNAS Volume
XNAS 29 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Kura Oncology Inc is on 08 Aug 2025 for the purpose of Kura Oncology Inc Second Quarter Earnings Results for 2025
See details
Medium Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks.
View Similar
Embed DVM
Kura Oncology Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..